LOCALIZATION AND QUANTIFICATION OF THE DOPAMINE TRANSPORTER - COMPARISON OF [H-3]WIN-35,428 AND [I-125]RTI-55

Citation
Cl. Coulter et al., LOCALIZATION AND QUANTIFICATION OF THE DOPAMINE TRANSPORTER - COMPARISON OF [H-3]WIN-35,428 AND [I-125]RTI-55, Brain research, 690(2), 1995, pp. 217-224
Citations number
54
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
00068993
Volume
690
Issue
2
Year of publication
1995
Pages
217 - 224
Database
ISI
SICI code
0006-8993(1995)690:2<217:LAQOTD>2.0.ZU;2-X
Abstract
Transport into the presynaptic terminal by the dopamine transporter is the primary mechanism for removing dopamine from the synaptic cleft. This transporter is a specific marker for dopamine terminals and is a primary site for CNS actions of cocaine. Several radioligands have bee n developed for analysis of the dopamine transporter. The ligands vary in affinity and specificity, leading to differences in reported trans porter density in brain regions. We compared two of the most commonly used ligands, [H-3]WIN 35,428 and [I-125]RTI-55, analyzing the localiz ation and density of sites in the rat brain using serial sections and quantitative autoradiography. Citalopram at 50 nmol/l was used to bloc k [I-125]RTI-55 binding to serotonin transport sites. Transporter dens ity was highest in the striatum and both ligands labeled equivalent nu mbers of sites, with lateral to medial and anterior to posterior gradi ents. In most areas the density of sites measured with the two ligands was similar. However, [I-125]RTI-55 binding was significantly higher than [H-3]WIN 35,428 binding in the substantia nigra zona compacta, ve ntral tegmental area, subthalamic nucleus and a number of other subcor tical nuclear groups while [H-3]WIN 35,428 binding was higher in later al striatum and in olfactory tubercle. These differences could reflect different forms of the transporter, perhaps due to post-translational modifications, and they may provide a basis for differential pharmaco logical regulation of transporter function in discrete brain regions a nd disease states.